Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monette

Showing results (691-700 of 740) with videos related to

Pageof 74
Sort By:
Journal of Athletic Training|May 2, 2023
Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus StatementJeffrey B Driban, Heather K Vincent, Thomas H Trojian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphomaChi Young Ok, Jiayu Chen, Zijun Y Xu-Monette, et al.
Journal of Hematology & Oncology|November 5, 2020
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53Manman Deng, Mingzhi Zhang, Zijun Y Xu-Monette, et al.
Journal of Athletic Training|May 2, 2023
Evidence Review for Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus Statement, Jeffrey B Driban, Heather K Vincent, et al.
Oncoimmunology|August 5, 2021
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphomaHua You, Zijun Y Xu-Monette, Li Wei, et al.
Aging|December 13, 2016
RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphomaMingzhi Zhang, Zijun Y Xu-Monette, Ling Li, et al.
The Lancet. Gastroenterology & Hepatology|December 12, 2024
Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trialGuillaume Martel, François Martin Carrier, Christopher Wherrett, et al.
The American Journal of Bioethics : AJOB|May 8, 2023
Returning Individual Research Results from Digital Phenotyping in PsychiatryFrancis X Shen, Matthew L Baum, Nicole Martinez-Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.
Oncotarget|September 2, 2015
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphomaLing Li, Zijun Y Xu-Monette, Chi Young Ok, et al.
Pageof 74

Showing results (691-700 of 740) with videos related to

Sort By:
Pageof 74
Journal of Athletic Training|May 2, 2023
Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus StatementJeffrey B Driban, Heather K Vincent, Thomas H Trojian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphomaChi Young Ok, Jiayu Chen, Zijun Y Xu-Monette, et al.
Journal of Hematology & Oncology|November 5, 2020
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53Manman Deng, Mingzhi Zhang, Zijun Y Xu-Monette, et al.
Journal of Athletic Training|May 2, 2023
Evidence Review for Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus Statement, Jeffrey B Driban, Heather K Vincent, et al.
Oncoimmunology|August 5, 2021
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphomaHua You, Zijun Y Xu-Monette, Li Wei, et al.
Aging|December 13, 2016
RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphomaMingzhi Zhang, Zijun Y Xu-Monette, Ling Li, et al.
The Lancet. Gastroenterology & Hepatology|December 12, 2024
Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trialGuillaume Martel, François Martin Carrier, Christopher Wherrett, et al.
The American Journal of Bioethics : AJOB|May 8, 2023
Returning Individual Research Results from Digital Phenotyping in PsychiatryFrancis X Shen, Matthew L Baum, Nicole Martinez-Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.
Oncotarget|September 2, 2015
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphomaLing Li, Zijun Y Xu-Monette, Chi Young Ok, et al.
Pageof 74